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Abstract 
Objectives 
This study aims to investigate the effectiveness of ECT as a treatment for postnatal 
depression compared with a matched non-postnatal population.  A secondary aim is 
to compare the number of ECT treatments needed to treat in both groups.   As the 
numbers in this study are small, this would act as a pilot study, allowing a power 
calculation to determine the numbers needed for a more definitive study. 
 
Methods 
Cases were identified from the local Scottish ECT Accreditation Network (SEAN) 
database.  12 patients had received ECT and had complete data from all those 
admitted to the Glasgow Mother and Baby Unit (MBU) since its opening.  Each case 
was matched to two controls who had also received ECT, and who were matched for 
age, sex, and severity of depressive symptoms.  It was not possible to find two 
controls for each case and 23 controls were allocated.  Severity was matched using 
the Montgomery-Asperg Depression Rating Scale (MADRS), which is completed for 
all patients receiving ECT in Scotland, at the beginning and end of their course.  As all 
controls were matched for initial severity of symptoms using MADRS, the change in 
MADRS score between both groups was compared. 
 
Results 
When comparing the mean change in MADRS score between both groups, it was 
seen that the perinatal patients score dropped by a mean of 10.09 points more than 
the controls (95% CI for difference -0.54, 20.73, P-Value 0.062). 
 
No difference was seen between the groups when comparing number of treatments 
(7.8 v 8). 
 
Conclusions 
Further research is required. 
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Introduction 
Severe postnatal mental illness is described as responding well to ECT. However, 
there are few studies in the literature which specifically address this issue. This study 
aims to compare the effectiveness of ECT in a population of women admitted to 
specialised inpatient mother and baby psychiatric care over a period of 9 years, with 
a population of women, matched for age and initial severity of depressive 
symptoms, who have also received inpatient ECT.  This should give some information 
on whether ECT is more effective for postnatal depression than for other cases of 
depression.  This project would be a pilot study to investigate whether further 
research into this topic is warranted.   
 
Background Information 
Untreated postnatal mental illness is associated with serious morbidity for the 
mother and the infant1.  Suicide is an important cause of maternal death, and self-
inflicted injury is the leading cause of one-year maternal mortality in the United 
Kingdom2.  Self-inflicted injury is also the second leading cause of maternal death in 
high income countries throughout the world, according to the World Health 
Organisation, and suicide remains an important cause of death in middle-to-low 
income countries3.  Postnatal mental illness also has a negative effect on the mother 
ability to interact properly with her child4.  Infanticide due to postnatal mental illness 
is a rare event, however a high proportion of such incidents occur in the context of 
postnatal mental illness5.  For these reasons, postnatal mental illness should be 
treated proactively. 
 
ECT is recognised to be an effective treatment option for depression postnatally; as 
it is for depression in the non-post-natal community6.  Studies into the use of ECT in 
the postnatal population however are very limited.  One small study of five women 
receiving ECT for postnatal depression reported a 100% remission rate7.  Another 
small study looked at ultra-brief pulse ECT in three postnatal women with depression 
and found this to be a useful treatment8.  Anecdotally amongst those who practice 
ECT, ECT is felt to be more effective in the perinatal population than in the general 
population of depressed patients.  More evidence is required to back this belief up.  
This study aims to provide more insight into the effectiveness of ECT in the postnatal 
population, particularly in comparison to the effectiveness of ECT in a non-perinatal 
female population.   
 
Materials and Methods 
All ECT given within Scotland is audited by the Scottish ECT Accreditation Network 
(SEAN).  As a result, all information pertaining to a patient receiving ECT within 
Scotland is stored on a local SEAN database.  Details collected include ICD-10 
diagnoses, indication for ECT, number of ƚƌĞĂƚŵĞŶƚƐ ? ĂƐ ǁĞůů ĂƐ ƚŚĞ ƉĂƚŝĞŶƚ ?Ɛ
personal details.  All patients also receive a MADRS before receiving ECT and also 
after their course is complete.  
 
All patients who have received ECT whilst inpatient on the mother and baby unit at 
the Southern General Hospital since 2005 were identified by Stephen Kelly, ECT co-
ordinator at the Leverndale ECT department using data collected on the SEAN 
database.  Each of these patients was then to be matched to two female patients 
who also received ECT at that department and who were within 5 years of age of the 
index patient, and also had an initial MADRS score within 5 points of their index 
patient.  The matched control patient must not have been a postnatal patient at the 
time of ECT.  Each control patient was only included once.  Only the first episode of 
ECT treatment was investigated for both groups. 
 
The machine used was a Thymatron IV ECT System, manufactured by Dantec 
Dynamics Limited, Garoner Way, Royal Portbury, Bristol BS20 7XE.    
 
All patients in both groups received bilateral, modified ECT throughout their 
treatments.  Dose titration was performed on all patients as per local protocols.  The 
local ECT department performs both bilateral and unilateral ECT, but bilateral ECT is 
generally given as first line treatment, with unilateral ECT only being considered if 
there are concerns about significant cognitive side effects, or if this is patient 
preference.   
 
All patients received ECT as per the NICE guidelines9. 
 
Ethical Considerations 
Ethical approval was sought via the NHS Heath Research Authority, and a 
proportionate review was asked for.  A proportionate review was sought as all 
information required for this study had been collected as part of routine practice and 
stored on the local SEAN database.  We proposed that data for the study would be 
collected anonymously using a care report form (CRF) by Stephen Kelly.  Consent was 
not sought from patients, as no new information was collected.  The anonymised 
data was then analysed by Dr Haxton and Mr Young.  Ethical approval was granted 
on these terms. 
 
Permission was also granted for the study by NHS Greater Glasgow and Clyde, and 
NHS Lothian.  SEAN granted permission for information to be collected from their 
database. 
 
Matching 
There were 14 patients identified who had received ECT whilst inpatients on the 
MBU since its opening.  Two patients had incomplete date on SEAN and were not 
included in the study for this reason.  This gave a total of 12 controls.  It was possible 
to find 20 controls who met all criteria of the original design.  Two controls were 
accepted who were within six years of age, rather than five.  One control was 
accepted who had an initial MADRS score within 6 points of the allocated case, 
rather than five.  There was one case where only one control was found that met the 
criteria.  This gave a total number of controls of 23.  The total number of subjects in 
this study was therefore 35. 
 
Statistical Analysis 
Statistical analysis was performed by David Young using Minitab (version 16) at a 5% 
significance level.  Between group comparisons were done using two-sample t-tests 
on the difference in MADRS scores. 
 
Baseline Comparison 
The two groups were well matched on baseline MADRS scores and the differences in 
scores were normally distributed. 
 
Table 1 
 
Figure 1 
Results 
The mean difference between the MADRS scores before and after receiving ECT was 
compared for both groups.  The perinatal cases had a mean MADRS score reduction 
10.09 points greater than the control group (95% CI for difference -0.54, 20.73, P-
Value = 0.062). 
  
No statistical difference was found between groups when comparing number of 
treatments (7.8 v 8). 
 
 
Conclusions 
Although the results for this study were short of being statistically significant, they 
do suggest an increased efficacy of ECT for the perinatal groups when compared 
with controls.  A larger study would be warranted to investigate these findings 
further.  This pilot study could be used to create a power calculation to decide on the 
numbers required for a larger study. 
 
Discussion 
It was known from early on in this project that the number of patients being 
investigated was going to be small, given that the mother and baby unit has six beds, 
and that about 4% of patients admitted to the unit since its opening have received 
ECT as a treatment. The attempt to match each case to two controls was to try and 
increase the power of the study given these small numbers.  The limits imposed on 
matching however made it difficult to do this however and not all cases received two 
controls.  Despite this however, the case and control groups were well matched for 
both age and initial MADRS score, and the results were almost significant. 
 
One of the difficulties encountered in the matching process was the fact that several 
of the perinatal cases had very high MADRS scores before receiving ECT, making it 
difficult to find a match with a similar initial score.  This reflects the severity of 
symptoms experiences by the patients admitted to the mother and baby unit, and 
the severity of those who require treatment with ECT in this group.   
 
The matching on age and MADRS opens up the possibility of various potential 
confounders.  It is not possible however, given the nature of this study to measure or 
analyse these.  These could potentially be explored in a larger study. 
 
Patients were not matched on diagnosis as it was felt that this would add extra 
difficulties when it came to matching.  However, as patients were matched for 
MADRS scores, the patients should have had similar depressive symptoms regardless 
of diagnosis.  Most had varying diagnoses of depression as their primary diagnosis.  
This is unsurprising given that the most common diagnosis treated with ECT in 
Scotland is depression10.  There was also one patient in the control groups who had 
schizoaffective disorder as their primary diagnosis, and two who had persistent 
mood disorders as their diagnosis.  Regardless of their diagnosis however, their main 
presentation at time of treatment would have been of depression, as backed up by 
their MADRS score.  One patient in the perinatal group did not have a diagnosis 
listed on the SEAN database.  Unfortunately the ethical approval granted for this 
study does not allow for review ŽĨ ƚŚĞ ƉĂƚŝĞŶƚ ?Ɛ ŶŽƚĞƐ ƚŽ ĚŝƐĐŽǀĞƌ ƚŚŝƐ ĚŝĂŐŶŽƐŝƐ ?
However, ECT would only have been used for depressive symptoms for patients 
admitted to the Glasgow Mother and Baby Unit.  25 % of the perinatal group had 
psychotic symptoms compared to 21.7% of the control group. 
 
Table 2 
 
Two patients in the control group had a secondary diagnosis.  One was recorded as 
having emotionally unstable personality disorder, whilst the other had a diagnosis of 
reaction to severe stress and adjustment disorder.  No perinatal cases had a 
secondary diagnosis recorded. 
 
There were also differences between the groups notes when comparing the severity 
of depressive symptoms according to their MADRS score after ECT. 
 
Figure 2 
 
As the groups were well matched for initial MADRS score, there is a similar spread of 
severity before ECT.  After ECT however, 50% of perinatal patients had no symptoms 
according to their MADRS score, compared to 17% in the control group.  There were 
also many more control patients who continued to have severe symptoms on the 
MADRS compared to the perinatal cases. 
 
Data on the relapse rates for both groups was not collected during this study.  It may 
be something that could be investigated in a larger project.  Other data that may be 
useful to explore could include data on prescribed medications at time of treatment, 
and data on quality of life. 
 
The results of this study have been used to complete a power calculation to guide 
any further studies of this area.  If a repeat study were to be completed, it would be 
desirable to have at least 35 participants in both the case and control groups to 
obtain a power of 80% at 5% significance. 
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Table 1 
 Number Mean Age Mean Initial 
MADRS 
Mean 
decrease in 
MADRS 
St DEV S E Mean 
Case 12 35.4 
(Range 28-
41) 
43.1 
(Range 27-
56) 
30.8 14.5 4.2 
Control 23 36.6 
(Range 27-
44) 
41.3 
(Range 31-
54) 
20.7 14.0 2.9 
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